Fig. 9 | Scientific Reports

Fig. 9

From: Cilazapril and benazepril mitigate neurodegeneration and α-synuclein accumulation in a cellular model of parkinson’s disease

Fig. 9The alternative text for this image may have been generated using AI.

(a) Total antioxidant capacity (TAC) results for cilazapril, which were significantly lower than those of the control group (*p < 0.05). (b) Total oxidant status (TOS) results for cilazapril, showing no statistically significant differences among the groups. (c) TAC results for benazepril, indicating a significant decrease relative to the control group (p < 0.05). (d) TOS results for benazepril, revealing a dose-dependent increase in oxidative status.

Back to article page